Manfred Rüdiger

Company: Ariceum Therapeutics

Job title: Chief Executive Officer & Managing Director

Seminars:

New Life for Satoreotide – The Antagonist Moves On 12:00 pm

• Update regarding satoreotide • Antagonist vs agonist, SST2 receptor • Neuroendocrine tumorsRead more

day: Day 1 Track A